Medicare Enrolled

Dr. Linda Tambascio Gibbons, PA

Dermatology · Norwood, MA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
95 CHAPEL ST, Norwood, MA 02062
7817625858
In practice since 2007 (19 years)
NPI: 1508918145 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tambascio Gibbons from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tambascio Gibbons? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tambascio Gibbons

Dr. Linda Tambascio Gibbons is a dermatology specialist in Norwood, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tambascio Gibbons performed 11,771 Medicare services across 1,603 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tambascio Gibbons received a total of $1,148 from 12 pharmaceutical and/or device companies across 45 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tambascio Gibbons is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 4% volume in MA $1,148 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,771
Medicare services
Top 4% in MA for dermatology
1,603
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~620 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Photodynamic therapy gel for precancerous skin 9,400 $1 $5
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
515 $5 $25
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
511 $60 $246
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
308 $39 $229
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
286 $82 $362
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
193 $71 $346
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
169 $83 $393
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
160 $39 $150
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
102 $40 $186
Light therapy to destroy precancerous skin growth
This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous.
31 $84 $375
Light application with debridement to destroy precancerous skin growth
This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths.
27 $207 $600
Punch biopsy of first skin growth
A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination.
24 $93 $435
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
21 $77 $275
Topical aminolevulinic acid HCl 20% solution
A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient.
13 $297 $680
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
11 $35 $254
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,148
Total received (2021-2024)
Avg $287/year across 4 years
Bottom 49% in MA for dermatology
12
Companies
45
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,148 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$421
2023
$293
2022
$332
2021
$102

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$253
Galderma Laboratories, L.P.
$46
E.R. Squibb & Sons, L.L.C.
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Lilly USA, LLC
$27
UCB, Inc.
$20
Top 3 companies account for 81.9% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$576
Incyte Corporation
$132
Amgen Inc.
$101
E.R. Squibb & Sons, L.L.C.
$59
Sun Pharmaceutical Industries Inc.
$49
PFIZER INC.
$48
Galderma Laboratories, L.P.
$46
LEO Pharma Inc.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Lilly USA, LLC
$27
UCB, Inc.
$20
Novartis Pharmaceuticals Corporation
$19
Top 3 companies account for 70.5% of all-time payments
Associated products mentioned in payments ›
ADBRY · Bimzelx · COSENTYX · CYLTEZO · EUCRISA · ILUMYA · OPZELURA · ORACEA · Otezla · RINVOQ · SKYRIZI · Sotyktu · TALTZ · Winlevi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in Norwood?
Compare dermatologists in the Norwood area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
402
Per 100K population
55.5
County median income
$126,497
Nearest hospital
NORWOOD HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tambascio Gibbons is a mixed practice specialist, with above-average Medicare volume (top 4% in MA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tambascio Gibbons experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Tambascio Gibbons performed 9,400 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tambascio Gibbons receive payments from pharmaceutical companies?
Yes. Dr. Tambascio Gibbons received a total of $1,148 from 12 companies across 45 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tambascio Gibbons's costs compare to other dermatologists in Norwood?
Dr. Tambascio Gibbons's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tambascio Gibbons) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →